A comprehensive database for cancer patient genomic and clinical data

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a detailed registry that compiles genomic, transcriptomic, molecular, and clinical characteristics of oncology patients. By collecting and analyzing this data, the study seeks to identify genomic and transcriptomic markers that can enhance clinical outcomes across various cancer types. Participants will provide clinical information linked to their genetic findings, which will be stored in a secure electronic database. The study does not involve any additional scans or procedures beyond standard care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Suspected or confirmed malignancy
2. Planned comprehensive genomic (\> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
3. Baseline demographics and treatment information available
4. Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
5. Signed informed consent to participate in the study.
6. Living in the United States at the time of enrollment

Exclusion Criteria:

Life expectancy \< 3 months

Where it's running

• BostonGene
  Waltham, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Nathan Fowler — BostonGene
• Study coordinator: Nathan Fowler, MD
• Email: nathan.fowler@bostongene.com
• Phone: +17815523131

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sedation Methods in PTBD: How Two Regimens Compare for Quality and Recovery

  This study tests two sedation plans (propofol with remifentanil vs propofol with ketamine) to see which helps patients recover faster after PTBD while staying comfortable and safe.

  Recruiting Ankara City Hospital Bilkent · Ankara, Ankara · NCT07640243

• Chest wall reconstruction using twisted stainless steel wires versus PMMA bone cement

  This project will test whether twisted stainless steel wires or PMMA bone cement gives better outcomes for adults needing chest wall reconstruction after tumor- or infection-related resections.

  Recruiting University of Health Sciences Lahore · Lahore, Punjab Province · NCT07338006

• Do repeated hyperbaric oxygen sessions increase DNA damage after radiotherapy?

  This tests whether repeated hyperbaric oxygen therapy sessions cause more DNA damage in adults who are receiving HBOT after prior radiotherapy or for related complications.

  Recruiting University Hospital, Angers · Angers · NCT06999785

• Capmatinib treatment for adults with cancers having MET gene changes

  This study is testing if capmatinib, a drug for lung cancer, can help adults with different types of cancers that have changes in the MET gene.

  Recruiting at 16 sites Phase 2/3 Cancer Research UK · Belfast and 16 other locations · NCT06988475

• Informatics-assisted detection of immune-related side effects to improve biorepository enrollment

  This project tests whether an automated system that reads electronic health records can help identify cancer patients on immunotherapy who are having immune-related side effects so they can be enrolled in a biorepository.

  Recruiting at 2 sites Phase 1/2 Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT06789601

• Imaging method for digestive system cancer using targeted PET scans

  This study is testing a new type of PET scan to see if it can better help doctors find and diagnose cancers in the digestive system.

  Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT06715839

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.